More experiences made possible by Benepali™

BENEPALi™.
THE ETANERCEPT FROM BIOGEN.

Learn more about how to use Benepali™

Benepali™: The leading etanercept in Europe1,a

Benepali™ (etanercept) indications

Benepali™ (etanercept) is indicated for the treatment of immune-mediated inflammatory diseases (rheumatological and dermatological diseases).

For more information

a Benepali™ is the etanercept market leader in the combined pharmaceutical markets in Europe where Benepali™ is launched and where we have data from IQVIA/MIDAS. Calculation based on single units (SU). Markets are: Austria, Belgium, Czech Rep, Denmark, France, Germany, Ireland, Italy, Luxembourg, Netherlands, Norway, Poland, Portugal, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK.

Dermatological
diseases

Rheumatological
diseases

How to use Benepali™ (etanercept) pen and syringe

Key safety information to help with Benepali™ (etanercept) use in clinical practice.

Benepali™ pre-filled pen

  • Audible Double Click3 – Confirms correct dosing, ensures intended benefit
  • Compact and Lightweight4 – Discrete and portable for patients
  • Latex Free2 – Reassurance for patients with latex allergy or their family
  • Medication Window3 – Confirms full dose delivery, maximising patient benefit
  • Button-free5 – Simple to use
For more information

Benepali™ pre-filled syringe

 

  • Stainless Steel6 – 27 gauge needle
  • Needle cover3
  • Plunger3
  • Latex Free2 – Reassurance for patients with latex allergy or their family
  • Ergonomic Finger Grip5
For more information
REFERENCES